WESTBURY... N.Y.... March 25... 2013 /PRNewswire/ — Vasomedical... Inc. (OTC BB: VASO)... announced today that it will release its financial results for the three months and year ended December 31... 2012 on Monday... April 1... 2013. The Company will host a conference call on Monday... April 1st at 1:00 p.m. ET featuring remarks by Jun Ma...
Read More

WESTBURY, N.Y., Dec. 10, 2012 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical” or the “Company”) (OTCBB: VASO) announced today that its shares of common stock have initiated trading via the Over-the-Counter Bulletin Board (OTCBB) under the ticker symbol “VASO”. The listing of the Company’s common stock on the OTCBB follows FINRA’s approval on December 3, 2012 of a 15c2-11...
Read More

WESTBURY... N.Y.... Nov. 27... 2012 /PRNewswire/ — On November 19... The American College of Cardiology Foundation and American Heart Association (ACCF/AHA) Task Force on Practice Guidelines issued its new Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease.  Enhanced external counterpulsation... or EECP®Therapy... a proprietary non-invasive cardiology treatment patented by Vasomedical... Inc....
Read More

WESTBURY, N.Y., Nov. 20, 2012 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTCQB: VASO) today reported its operating results for the three- and nine-month periods ended September 30, 2012. “We reported another strong quarter of sales for our equipment segment in the third quarter.  However, changes to certain sales commission milestones for 2012 compared to 2011 have resulted...
Read More

WESTBURY, N.Y., Nov. 15, 2012 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTCQB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices for noninvasive cardiology including EECP® systems, the gold standard of ECP therapy, announced today that it was named to Deloitte’s Technology Fast 500™, a ranking of the fastest growing...
Read More